NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 51 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,000 | -72.7% | 22,309 | +28.4% | 0.00% | – |
| Q1 2022 | $33,000 | -57.1% | 17,375 | -36.2% | 0.00% | – |
| Q4 2021 | $77,000 | -24.5% | 27,252 | -3.4% | 0.00% | – |
| Q3 2021 | $102,000 | -87.8% | 28,200 | -83.8% | 0.00% | -100.0% |
| Q2 2021 | $834,000 | +143.9% | 174,020 | +276.2% | 0.00% | – |
| Q1 2021 | $342,000 | +147.8% | 46,253 | +134.8% | 0.00% | – |
| Q4 2020 | $138,000 | -96.3% | 19,697 | -95.3% | 0.00% | -100.0% |
| Q2 2020 | $3,682,000 | +2104.8% | 419,325 | +1689.3% | 0.01% | – |
| Q1 2020 | $167,000 | -18.9% | 23,435 | -18.2% | 0.00% | – |
| Q4 2019 | $206,000 | – | 28,653 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | 939,412 | $371,000 | 0.21% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 470,524 | $186,000 | 0.20% |
| CM Management, LLC | 450,000 | $178,000 | 0.20% |
| Decheng Capital Management III (Cayman), LLC | 1,000,000 | $395,000 | 0.14% |
| AIGH Capital Management LLC | 872,023 | $345,000 | 0.11% |
| Greenlight Capital | 2,727,027 | $1,077,000 | 0.08% |
| Worth Venture Partners, LLC | 212,035 | $84,000 | 0.05% |
| PERKINS CAPITAL MANAGEMENT INC | 98,000 | $39,000 | 0.04% |
| Sio Capital Management, LLC | 259,441 | $102,000 | 0.03% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 311,000 | $123,000 | 0.00% |